The UK government has backed the creation of an “accelerated access pathway” (AAP) under which a handful of selected breakthrough innovations – drugs, medical devices, diagnostics and digital products – could reach patients up to four years earlier than under standard assessment procedures.
The new pathway, to be introduced in April 2018, is expected to shorten the overall time to market for certain...







